Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury - PubMed (original) (raw)
. 2007 Jan;292(1):H503-9.
doi: 10.1152/ajpheart.00642.2006. Epub 2006 Sep 15.
Affiliations
- PMID: 16980352
- DOI: 10.1152/ajpheart.00642.2006
Free article
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Yasushi Sakata et al. Am J Physiol Heart Circ Physiol. 2007 Jan.
Free article
Abstract
Production of proinflammatory cytokines contributes to cardiac dysfunction during ischemia-reperfusion. The principal mechanism responsible for the induction of this innate stress response during periods of myocardial ischemia-reperfusion remains unknown. Toll-like receptor 2 (TLR2) is a highly conserved pattern recognition receptor that has been implicated in the innate immune response to a variety of pathogens. However, TLR2 may also mediate inflammation in response to noninfectious injury. We therefore hypothesized that TLR2 is essential for modulating myocardial inflammation and left ventricular (LV) function during ischemia-reperfusion injury. Susceptibility to myocardial ischemia-reperfusion injury following ischemia-reperfusion was determined in Langendorff-perfused hearts isolated from wild-type mice and mice deficient in TLR2 (TLR2D) and Toll interleukin receptor domain-containing adaptor protein. After ischemia-reperfusion, contractile performance was significantly impaired in hearts from wild-type mice as demonstrated by a lower recovery of LV developed pressure relative to TLR2D hearts. Creatinine kinase levels were similar in both groups after reperfusion. Contractile dysfunction in wild-type hearts was associated with elevated cardiac levels of TNF and IL-1beta. Ischemia-reperfusion-induced LV dysfunction was reversed by treatment with the recombinant TNF blocking protein etanercept. These studies show for the first time that TLR2 signaling importantly contributes to the LV dysfunction that occurs following ischemia-reperfusion. Thus disruption of TLR2-mediated signaling may be helpful to induce immediate or delayed myocardial protection from ischemia-reperfusion injury.
Similar articles
- Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways.
Dong JW, Vallejo JG, Tzeng HP, Thomas JA, Mann DL. Dong JW, et al. Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1079-87. doi: 10.1152/ajpheart.00306.2009. Epub 2010 Jan 8. Am J Physiol Heart Circ Physiol. 2010. PMID: 20061547 Free PMC article. - Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia.
Cha J, Wang Z, Ao L, Zou N, Dinarello CA, Banerjee A, Fullerton DA, Meng X. Cha J, et al. Ann Thorac Surg. 2008 May;85(5):1678-85. doi: 10.1016/j.athoracsur.2008.01.043. Ann Thorac Surg. 2008. PMID: 18442564 Free PMC article. - Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
Bagchi AK, Akolkar G, Mandal S, Ayyappan P, Yang X, Singal PK. Bagchi AK, et al. Am J Physiol Heart Circ Physiol. 2017 Jun 1;312(6):H1238-H1247. doi: 10.1152/ajpheart.00800.2016. Epub 2017 Apr 21. Am J Physiol Heart Circ Physiol. 2017. PMID: 28432060 - Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart.
Knuefermann P, Sakata Y, Baker JS, Huang CH, Sekiguchi K, Hardarson HS, Takeuchi O, Akira S, Vallejo JG. Knuefermann P, et al. Circulation. 2004 Dec 14;110(24):3693-8. doi: 10.1161/01.CIR.0000143081.13042.04. Epub 2004 Nov 29. Circulation. 2004. PMID: 15569836 - Toll-like receptor and its roles in myocardial ischemic/reperfusion injury.
Fang Y, Hu J. Fang Y, et al. Med Sci Monit. 2011 Apr;17(4):RA100-9. doi: 10.12659/msm.881709. Med Sci Monit. 2011. PMID: 21455117 Free PMC article. Review.
Cited by
- Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms.
Maslov LN, Popov SV, Mukhomedzyanov AV, Naryzhnaya NV, Voronkov NS, Ryabov VV, Boshchenko AA, Khaliulin I, Prasad NR, Fu F, Pei JM, Logvinov SV, Oeltgen PR. Maslov LN, et al. Curr Cardiol Rev. 2022;18(5):63-79. doi: 10.2174/1573403X18666220413121730. Curr Cardiol Rev. 2022. PMID: 35422224 Free PMC article. Review. - Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.
Rodríguez-Sinovas A, Sánchez JA, Valls-Lacalle L, Consegal M, Ferreira-González I. Rodríguez-Sinovas A, et al. Int J Mol Sci. 2021 Apr 23;22(9):4413. doi: 10.3390/ijms22094413. Int J Mol Sci. 2021. PMID: 33922534 Free PMC article. Review. - Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success.
Silvis MJM, Kaffka Genaamd Dengler SE, Odille CA, Mishra M, van der Kaaij NP, Doevendans PA, Sluijter JPG, de Kleijn DPV, de Jager SCA, Bosch L, van Hout GPJ. Silvis MJM, et al. Front Immunol. 2020 Dec 8;11:599511. doi: 10.3389/fimmu.2020.599511. eCollection 2020. Front Immunol. 2020. PMID: 33363540 Free PMC article. Review. - Blocking Extracellular Chaperones to Improve Cardiac Regeneration.
Seclì L, Sorge M, Morotti A, Brancaccio M. Seclì L, et al. Front Bioeng Biotechnol. 2020 May 26;8:411. doi: 10.3389/fbioe.2020.00411. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32528937 Free PMC article. - Ischemic postconditioning attenuates the inflammatory response in ischemia/reperfusion myocardium by upregulating miR‑499 and inhibiting TLR2 activation.
Zhang XY, Huang Z, Li QJ, Zhong GQ, Meng JJ, Wang DX, Tu RH. Zhang XY, et al. Mol Med Rep. 2020 Jul;22(1):209-218. doi: 10.3892/mmr.2020.11104. Epub 2020 Apr 30. Mol Med Rep. 2020. PMID: 32377693 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- HL-58081/HL/NHLBI NIH HHS/United States
- R01 GM062508/GM/NIGMS NIH HHS/United States
- GM-62474/GM/NIGMS NIH HHS/United States
- HL-073017/HL/NHLBI NIH HHS/United States
- HL-42250/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases